SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-17-000094
Filing Date
2017-02-02
Accepted
2017-02-02 09:23:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D e615710_sc13d-alcobra.htm SC 13D 263809
2 JOINT FILING AGREEMENT e615710_ex99-1.htm EX-99.1 18196
  Complete submission text file 0001193805-17-000094.txt   283539
Mailing Address AZRIELI TRIANGLE BUILDING 132 DERECH MENACHEM BEGIN, 39TH FLOOR TEL AVIV L3 6701101
Business Address AZRIELI TRIANGLE BUILDING 132 DERECH MENACHEM BEGIN, 39TH FLOOR TEL AVIV L3 6701101 972722204661
ALCOBRA LTD. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: SC 13D | Act: 34 | File No.: 005-87471 | Film No.: 17566975
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104
Business Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104 972-77-3206050
Brosh Capital L.P. (Filed by) CIK: 0001696743 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D